Even-Sapir E - Search Results

1

The significance of equivocal bone findings in staging PSMA imaging in the preoperative setting: validation of the PSMA-RADS version 1.0.

Kuten J, Dekalo S, Mintz I, Yossepowitch O, Mano R, Even-Sapir E. Kuten J, et al. EJNMMI Res. 2021 Jan 6;11(1):3. doi: 10.1186/s13550-020-00745-8. EJNMMI Res. 2021. PMID: 33409930 Free PMC article.

2

(99m)Tc-MDP bone scintigraphy of the hand: comparing the use of novel cadmium zinc telluride (CZT) and routine NaI(Tl) detectors.

Koulikov V, Lerman H, Kesler M, Even-Sapir E. Koulikov V, et al. EJNMMI Res. 2015 Dec;5(1):63. doi: 10.1186/s13550-015-0139-6. Epub 2015 Nov 14. EJNMMI Res. 2015. PMID: 26566952 Free PMC article.

3

Ga-PSMA PET/CT Staging of Newly Diagnosed Intermediate- and High-Risk Prostate Cancer.

Kuten J, Mabjeesh NJ, Lerman H, Levine C, Barnes S, Even-Sapir E. Kuten J, et al. Isr Med Assoc J. 2019 Feb;21(2):100-104. Isr Med Assoc J. 2019. PMID: 30772960 Free article.

4

68Ga-PSMA PET/CT: Does it predict adverse pathology findings at radical prostatectomy?

Dekalo S, Kuten J, Mabjeesh NJ, Beri A, Even-Sapir E, Yossepowitch O. Dekalo S, et al. Urol Oncol. 2019 Sep;37(9):574.e19-574.e24. doi: 10.1016/j.urolonc.2019.05.015. Epub 2019 Jun 14. Urol Oncol. 2019. PMID: 31204017

5

[⁶⁸Ga]Ga-PSMA-11 PET/CT for monitoring response to treatment in metastatic prostate cancer: is there any added value over standard follow-up?

Kuten J, Sarid D, Yossepowitch O, Mabjeesh NJ, Even-Sapir E. Kuten J, et al. EJNMMI Res. 2019 Aug 29;9(1):84. doi: 10.1186/s13550-019-0554-1. EJNMMI Res. 2019. PMID: 31468235 Free PMC article.

6

Node positive breast cancer: Concordance between baseline PET/CT and sentinel node assessment after neoadjuvant therapy.

Christin OL, Kuten J, Even-Sapir E, Klausner J, Menes TS. Christin OL, et al. Surg Oncol. 2019 Sep;30:1-5. doi: 10.1016/j.suronc.2019.05.006. Epub 2019 May 18. Surg Oncol. 2019. PMID: 31500769

7

Head-to-Head Comparison of ⁶⁸Ga-PSMA-11 with ¹⁸F-PSMA-1007 PET/CT in Staging Prostate Cancer Using Histopathology and Immunohistochemical Analysis as a Reference Standard.

Kuten J, Fahoum I, Savin Z, Shamni O, Gitstein G, Hershkovitz D, Mabjeesh NJ, Yossepowitch O, Mishani E, Even-Sapir E. Kuten J, et al. J Nucl Med. 2020 Apr;61(4):527-532. doi: 10.2967/jnumed.119.234187. Epub 2019 Sep 27. J Nucl Med. 2020. PMID: 31562225 Free article.

8

Personalized radiation dosimetry for PRRT-how many scans are really required?

Freedman N, Sandström M, Kuten J, Shtraus N, Ospovat I, Schlocker A, Even-Sapir E. Freedman N, et al. EJNMMI Phys. 2020 May 11;7(1):26. doi: 10.1186/s40658-020-00293-z. EJNMMI Phys. 2020. PMID: 32394075 Free PMC article.

9

[18F] FDOPA PET may confirm the clinical diagnosis of Parkinson's disease by imaging the nigro-striatal pathway and the sympathetic cardiac innervation: Proof-of-concept study.

Kuten J, Linevitz A, Lerman H, Freedman N, Kestenbaum M, Shiner T, Giladi N, Even-Sapir E. Kuten J, et al. J Integr Neurosci. 2020 Sep 30;19(3):489-494. doi: 10.31083/j.jin.2020.03.196. J Integr Neurosci. 2020. PMID: 33070528 Free article.

10

68Ga-PSMA-11 PET/CT Follow-Up of Patients with Prostate Cancer with Bone Metastases Who Had Reduced Bone Density after Androgen Deprivation Therapy.

Kesler M, Druckmann I, Levine C, Kuten J, Yossepowitch O, Even-Sapir E. Kesler M, et al. Diagnostics (Basel). 2021 Feb 10;11(2):277. doi: 10.3390/diagnostics11020277. Diagnostics (Basel). 2021. PMID: 33578990 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters